Lake Forest, CA – Crossroads Neurovascular, Inc. is proud to announce that the U.S. Food and Drug
Administration (FDA) has granted 510(k) clearance (K242392) for its groundbreaking PATH BGC™, a
next-generation balloon guide catheter (BGC) designed to advance neurovascular intervention. With
this clearance, PATH BGC becomes the world’s first BGC engineered specifically for neurovascular
use that is fully compatible with a 7F system, offering greater procedural flexibility and enabling
access in smaller and more distal arteries where traditional BGCs cannot reach.
PATH BGC: Purpose-Built for Complex Anatomy
Developed with input from leading neurointerventionalists, PATH BGC is designed to address the
challenges of navigating tortuous anatomy and accessing distal targets during stroke and other
neurovascular procedures. Key features include:
• 7F Sheath Compatibility – First BGC on the market capable of safe use through a 7F sheath,
allowing access to vessels that were previously inaccessible with standard BGCs.
• Extended Tip Design (2 cm) – Uniquely long distal tip enables significantly closer and safer
access to the target lesion. This improves aspiration efficacy, increases the likelihood of
procedural success, and reduces the risk of distal embolization.
• Optimized for Tortuous Anatomy – Advanced shaft engineering provides exceptional trackability,
even through complex arterial pathways.
• Enhanced Kink Resistance and Stability – Engineered to resist kinking and minimize catheter
kickback during device exchanges and delivery, particularly in challenging aortic arch anatomy.
The PATH BGC™ establishes a new standard in neurovascular intervention by enabling safe and precise
access to distal anatomy. Its advanced design enhances physician control during procedures,
supporting more effective treatment and improved outcomes for patients with ischemic stroke and
other complex cerebrovascular conditions.
About Crossroads Neurovascular, Inc.
Crossroads Neurovascular is a medical device company committed to advancing cerebrovascular
intervention through innovation and purposeful design. With a portfolio focused on simplifying
access and improving outcomes, Crossroads aims to empower clinicians with tools that redefine
neurovascular care.
For more information, contact:
info@crossroadsneuro.com
